Dasatinib
![listen](https://webarchive.library.unt.edu/web/20120928122454im_/http://www.cancer.gov/images/audio-icon.gif)
This page contains brief information about dasatinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
US Brand Name(s): | ![]() | Sprycel |
![]() | ||
![]() | ||
FDA Approved: | ![]() | Yes |
Dasatinib is approved to treat:
- Acute lymphoblastic leukemia that is Philadelphia chromosome positive in patients who are not able to use other drugs.
- Chronic myelogenous leukemia that is Philadelphia chromosome positive. It may be used in patients who are not able to use other drugs.
Dasatinib is also being studied in the treatment of other types of cancer.
More About DasatinibDefinition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Dasatinib - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.
Targeted Cancer Therapies - Information about the use of this drug to treat cancer.
Research ResultsClinical Trial Results: Trials Point to More Treatment Options for Chronic Myeloid Leukemia - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Dasatinib and Nilotinib Both Effective for Chronic Myelogenous Leukemia When Imatinib Won't Work - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Dasatinib Effective Against Difficult-to-Treat Acute Lymphoblastic Leukemia - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trial Results: Dasatinib Effective in Blast-Crisis Chronic Myeloid Leukemia - Important clinical trial results for this drug, background information, and how the trial was done.
Clinical Trials Accepting PatientsFind Clinical Trials for Dasatinib - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.